212 related articles for article (PubMed ID: 26688192)
1. Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs.
Abdul Razzaq B; Scalora A; Koparde VN; Meier J; Mahmood M; Salman S; Jameson-Lee M; Serrano MG; Sheth N; Voelkner M; Kobulnicky DJ; Roberts CH; Ferreira-Gonzalez A; Manjili MH; Buck GA; Neale MC; Toor AA
Biol Blood Marrow Transplant; 2016 May; 22(5):850-61. PubMed ID: 26688192
[TBL] [Abstract][Full Text] [Related]
2. Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation.
Koparde V; Abdul Razzaq B; Suntum T; Sabo R; Scalora A; Serrano M; Jameson-Lee M; Hall C; Kobulnicky D; Sheth N; Feltz J; Contaifer D; Wijesinghe D; Reed J; Roberts C; Qayyum R; Buck G; Neale M; Toor A
PLoS One; 2017; 12(12):e0187771. PubMed ID: 29194460
[TBL] [Abstract][Full Text] [Related]
3. Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.
Salman A; Koparde V; Hall CE; Jameson-Lee M; Roberts C; Serrano M; AbdulRazzaq B; Meier J; Kennedy C; Manjili MH; Spellman SR; Wijesinghe D; Hashmi S; Buck G; Qayyum R; Neale M; Reed J; Toor AA
Front Immunol; 2018; 9():2284. PubMed ID: 30364159
[TBL] [Abstract][Full Text] [Related]
4. In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation.
Jameson-Lee M; Koparde V; Griffith P; Scalora AF; Sampson JK; Khalid H; Sheth NU; Batalo M; Serrano MG; Roberts CH; Hess ML; Buck GA; Neale MC; Manjili MH; Toor AA
Front Immunol; 2014; 5():529. PubMed ID: 25414699
[TBL] [Abstract][Full Text] [Related]
5. Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.
Hall CE; Koparde VN; Jameson-Lee M; Elnasseh AG; Scalora AF; Kobulnicky DJ; Serrano MG; Roberts CH; Buck GA; Neale MC; Nixon DE; Toor AA
PLoS One; 2017; 12(8):e0178763. PubMed ID: 28800601
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
[TBL] [Abstract][Full Text] [Related]
9. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
Meier JA; Haque M; Fawaz M; Abdeen H; Coffey D; Towlerton A; Abdeen A; Toor A; Warren E; Reed J; Kanakry CG; Keating A; Luznik L; Toor AA
Biol Blood Marrow Transplant; 2019 May; 25(5):868-882. PubMed ID: 30677510
[TBL] [Abstract][Full Text] [Related]
10. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
11. Fractal organization of the human T cell repertoire in health and after stem cell transplantation.
Meier J; Roberts C; Avent K; Hazlett A; Berrie J; Payne K; Hamm D; Desmarais C; Sanders C; Hogan KT; Archer KJ; Manjili MH; Toor AA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):366-77. PubMed ID: 23313705
[TBL] [Abstract][Full Text] [Related]
12. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
13. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
14. Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing.
Arrieta-Bolaños E; Crivello P; Metzing M; Meurer T; Ahci M; Rytlewski J; Vignali M; Yusko E; van Balen P; Horn PA; Falkenburg JHF; Fleischhauer K
Front Immunol; 2018; 9():280. PubMed ID: 29520276
[TBL] [Abstract][Full Text] [Related]
15. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
16. Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation.
Sampson JK; Sheth NU; Koparde VN; Scalora AF; Serrano MG; Lee V; Roberts CH; Jameson-Lee M; Ferreira-Gonzalez A; Manjili MH; Buck GA; Neale MC; Toor AA
Br J Haematol; 2014 Aug; 166(4):566-70. PubMed ID: 24749631
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Thymic function and allogeneic T-cell responses in stem-cell transplantation.
Komanduri KV
Cytotherapy; 2002; 4(4):333-42. PubMed ID: 12396833
[TBL] [Abstract][Full Text] [Related]
19. Effect of one-HLA-haplotype-matched and HLA-mismatched blood transfusions on recipient T lymphocyte allorepertoires.
Young NT; Roelen DL; Iggo N; Gray DW; Roake JA; Graham V; Wood KJ; Dallman MJ; Welsh KI; Morris PJ
Transplantation; 1997 Apr; 63(8):1160-5. PubMed ID: 9133479
[TBL] [Abstract][Full Text] [Related]
20. A New Window into the Human Alloresponse.
DeWolf S; Shen Y; Sykes M
Transplantation; 2016 Aug; 100(8):1639-49. PubMed ID: 26760572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
